DCF Advisers, LLC Buys Xencor Inc, Esperion Therapeutics Inc, Verizon Communications Inc, Sells Bristol-Myers Squibb Company, Square Inc, Berkshire Hathaway Inc

Article's Main Image
Investment company DCF Advisers, LLC (Current Portfolio) buys Xencor Inc, Esperion Therapeutics Inc, Verizon Communications Inc, Target Corp, Alexion Pharmaceuticals Inc, sells Bristol-Myers Squibb Company, Square Inc, Berkshire Hathaway Inc, General Motors Co, VanEck Vectors Gold Miners during the 3-months ended 2020Q2, according to the most recent filings of the investment company, DCF Advisers, LLC. As of 2020Q2, DCF Advisers, LLC owns 57 stocks with a total value of $146 million. These are the details of the buys and sells.

For the details of DCF Advisers, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/dcf+advisers%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of DCF Advisers, LLC
  1. SPDR GOLD TRUST (GLD) - 70,000 shares, 8.00% of the total portfolio. Shares added by 7.69%
  2. Intra-Cellular Therapies Inc (ITCI) - 425,500 shares, 7.46% of the total portfolio. Shares reduced by 1.62%
  3. Alphabet Inc (GOOG) - 6,650 shares, 6.42% of the total portfolio. Shares added by 3.10%
  4. Micron Technology Inc (MU) - 157,500 shares, 5.54% of the total portfolio. Shares reduced by 3.08%
  5. Regeneron Pharmaceuticals Inc (REGN) - 12,400 shares, 5.28% of the total portfolio. Shares added by 2.06%
New Purchase: Target Corp (TGT)

DCF Advisers, LLC initiated holding in Target Corp. The purchase prices were between $92.57 and $125.2, with an estimated average price of $113.71. The stock is now traded at around $136.90. The impact to a portfolio due to this purchase was 0.41%. The holding were 5,000 shares as of .

New Purchase: Genmab A/S (GMAB)

DCF Advisers, LLC initiated holding in Genmab A/S. The purchase prices were between $20.05 and $33.89, with an estimated average price of $27.12. The stock is now traded at around $37.02. The impact to a portfolio due to this purchase was 0.29%. The holding were 12,500 shares as of .

New Purchase: Vir Biotechnology Inc (VIR)

DCF Advisers, LLC initiated holding in Vir Biotechnology Inc. The purchase prices were between $27.89 and $47.86, with an estimated average price of $33.51. The stock is now traded at around $52.95. The impact to a portfolio due to this purchase was 0.21%. The holding were 7,500 shares as of .

New Purchase: Turning Point Brands Inc (TPB)

DCF Advisers, LLC initiated holding in Turning Point Brands Inc. The purchase prices were between $19.68 and $25.65, with an estimated average price of $22.92. The stock is now traded at around $31.04. The impact to a portfolio due to this purchase was 0.17%. The holding were 9,750 shares as of .

Added: Xencor Inc (XNCR)

DCF Advisers, LLC added to a holding in Xencor Inc by 126.63%. The purchase prices were between $27.76 and $33.42, with an estimated average price of $30.65. The stock is now traded at around $34.20. The impact to a portfolio due to this purchase was 2.35%. The holding were 190,367 shares as of .

Added: Esperion Therapeutics Inc (ESPR)

DCF Advisers, LLC added to a holding in Esperion Therapeutics Inc by 120.45%. The purchase prices were between $30.04 and $51.31, with an estimated average price of $41.62. The stock is now traded at around $33.63. The impact to a portfolio due to this purchase was 0.93%. The holding were 48,500 shares as of .

Added: Verizon Communications Inc (VZ)

DCF Advisers, LLC added to a holding in Verizon Communications Inc by 43.75%. The purchase prices were between $52.92 and $58.46, with an estimated average price of $56.2. The stock is now traded at around $59.18. The impact to a portfolio due to this purchase was 0.66%. The holding were 57,500 shares as of .

Added: Alexion Pharmaceuticals Inc (ALXN)

DCF Advisers, LLC added to a holding in Alexion Pharmaceuticals Inc by 44.44%. The purchase prices were between $89.77 and $119.9, with an estimated average price of $105.7. The stock is now traded at around $103.31. The impact to a portfolio due to this purchase was 0.31%. The holding were 13,000 shares as of .

Added: VANECK VECTORS ETF (GDXJ)

DCF Advisers, LLC added to a holding in VANECK VECTORS ETF by 21.43%. The purchase prices were between $28.1 and $49.58, with an estimated average price of $42.12. The stock is now traded at around $60.71. The impact to a portfolio due to this purchase was 0.25%. The holding were 42,500 shares as of .

Added: Intel Corp (INTC)

DCF Advisers, LLC added to a holding in Intel Corp by 50.00%. The purchase prices were between $51.88 and $64.34, with an estimated average price of $59.71. The stock is now traded at around $48.65. The impact to a portfolio due to this purchase was 0.2%. The holding were 15,000 shares as of .

Sold Out: Square Inc (SQ)

DCF Advisers, LLC sold out a holding in Square Inc. The sale prices were between $43.72 and $104.94, with an estimated average price of $76.

Sold Out: General Motors Co (GM)

DCF Advisers, LLC sold out a holding in General Motors Co. The sale prices were between $18.04 and $30.68, with an estimated average price of $24.29.

Sold Out: JPMorgan Chase & Co (JPM)

DCF Advisers, LLC sold out a holding in JPMorgan Chase & Co. The sale prices were between $84.03 and $113.45, with an estimated average price of $94.84.

Sold Out: Adobe Inc (ADBE)

DCF Advisers, LLC sold out a holding in Adobe Inc. The sale prices were between $293.61 and $440.55, with an estimated average price of $369.18.

Sold Out: Kohl's Corp (KSS)

DCF Advisers, LLC sold out a holding in Kohl's Corp. The sale prices were between $11.51 and $28.83, with an estimated average price of $19.19.

Sold Out: Blackrock Enhanced International Dividend Trust (BGY)

DCF Advisers, LLC sold out a holding in Blackrock Enhanced International Dividend Trust. The sale prices were between $4.38 and $5.3, with an estimated average price of $4.94.



Here is the complete portfolio of DCF Advisers, LLC. Also check out:

1. DCF Advisers, LLC's Undervalued Stocks
2. DCF Advisers, LLC's Top Growth Companies, and
3. DCF Advisers, LLC's High Yield stocks
4. Stocks that DCF Advisers, LLC keeps buying